African Journal of Urology (Jan 2021)

An unusual outcome of papillary renal cell carcinoma with lung metastases: a case report and review of literature

  • Emmanuel Owusu Ofori,
  • Baba Alhaji Bin Alhassan,
  • Edwina Ayaaba Ayabilah,
  • Patrick Opoku Manu Maison,
  • Alvin Asante-Asamani,
  • Henry Atawura,
  • Ganiyu Adebisi Rahman,
  • Patrick Kafui Akakpo,
  • Emmanuel Gustav Imbeah,
  • Prince Wilson Ofori

DOI
https://doi.org/10.1186/s12301-020-00103-z
Journal volume & issue
Vol. 27, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Renal cell carcinoma (RCC) is a heterogeneous group of malignant epithelial tumors of the kidney. It accounts for more than 90% of all kidney cancers. However, papillary RCC is the second most common histologic subtype representing 10–15% of all RCCs. The mean age of presentation for papillary RCC ranges between 59 and 63 years but more importantly when RCC is diagnosed at a younger age, the possibility of an underlying hereditary kidney cancer syndrome should be considered. RCC potentially metastasizes to many different organs with lung being the commonest site accounting for 45.2%. The treatment for metastatic RCC is mostly multimodal for most patients. However, patients with untreated pulmonary metastases have been observed to have very poor prognosis with a 5-year overall survival rate of only 5% or even less and thus the need to report on the unusual outcome of our patient who had a metastatic disease. Case presentation The present study reports a papillary renal cell carcinoma with multiple lung metastases in a 31-year-old woman who presented with progressive right flank mass and pain with no chest symptoms. She underwent cytoreductive radical nephrectomy via a right subcostal incision. Patient, however, did not undergo metastasectomy nor palliative systemic therapy and was seen 5 years post-nephrectomy. Conclusion Our patient with metastatic RCC, without undergoing metastasectomy nor palliative systemic therapy, remained stable with 5-year progression-free survival post-cytoreductive nephrectomy.

Keywords